When is Aidoc the better choice?

It works on the image, running detection models across an imaging estate through an operating system that handles normalisation, monitoring and governance for every model it runs. The January 2026 clearance covers many acute indications from a single named foundation model, with performance from a regulator reviewed pivotal study rather than a vendor benchmark. For a department whose problem is that urgent findings wait in the queue, detection and worklist reprioritisation is the intervention.

When is Rad AI the better choice?

It works on the report, generating the impression from the radiologist's own dictated findings and learning that radiologist's language from their prior reports. The oversight model is structurally the clearest in this index because the workflow enforces it: the model drafts and the radiologist signs, so no unread text reaches a released report. It publishes specific falsifiable operational figures with named baselines, including follow up completion, rather than adoption counts.

Aidoc vs Rad AI

Last VerifiedAugust 4, 2026

Verdict

The two most commonly shortlisted radiology AI purchases, and they do not overlap at all. Aidoc works on the image, running detection models across the imaging estate through an operating system that handles normalisation, monitoring and governance, with a 2026 clearance covering many acute indications from one named foundation model. Rad AI never touches the image, generating the report impression from the radiologist's own dictated findings and learning their individual language from prior reports, with the clearest structural oversight model in this index because the workflow enforces it. Detection changes which study gets read next; reporting changes how long each one takes to finish. If your backlog is turnaround time on urgent findings, Aidoc. If it is that radiologists are reading fast and reporting slowly, Rad AI is aimed at the actual bottleneck.

Select Aidoc if

It works on the image, running detection models across an imaging estate through an operating system that handles normalisation, monitoring and governance for every model it runs.
The January 2026 clearance covers many acute indications from a single named foundation model, with performance from a regulator reviewed pivotal study rather than a vendor benchmark.
For a department whose problem is that urgent findings wait in the queue, detection and worklist reprioritisation is the intervention.

Select Rad AI if

It works on the report, generating the impression from the radiologist's own dictated findings and learning that radiologist's language from their prior reports.
The oversight model is structurally the clearest in this index because the workflow enforces it: the model drafts and the radiologist signs, so no unread text reaches a released report.
It publishes specific falsifiable operational figures with named baselines, including follow up completion, rather than adoption counts.

Attribute Matrix

Side by Side

Axis	A Aidoc	R Rad AI
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.

Aidoc vs Bunkerhill Health→Aidoc vs Qure AI→Aidoc vs Subtle Medical→Aidoc vs Viz.ai→Rad AI vs TeraRecon→

Disclosure

These are complementary and a large department will plausibly run both, so the useful question is sequencing rather than selection: detection changes which study is read next, reporting changes how long each study takes to finish. Rad AI holds no clearance for any product in its portfolio, which is consistent with reporting assistance rather than diagnosis but should be checked against how your department intends to use carried forward prior findings. Neither publishes pricing. Neither publishes subgroup performance, and for detection models trained on particular scanner and protocol mixes, local validation before go live is the diligence that gets skipped most often.